AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 114 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $53,000 | -71.7% | 881,676 | -20.3% | 0.00% | – |
| Q2 2022 | $187,000 | -61.8% | 1,106,288 | +6.4% | 0.00% | – |
| Q1 2022 | $489,000 | -44.6% | 1,039,483 | -32.7% | 0.00% | – |
| Q4 2021 | $882,000 | -21.8% | 1,544,866 | +127.5% | 0.00% | – |
| Q3 2021 | $1,128,000 | -42.0% | 679,081 | -41.7% | 0.00% | – |
| Q2 2021 | $1,945,000 | -37.3% | 1,164,480 | -36.6% | 0.00% | – |
| Q1 2021 | $3,104,000 | -41.6% | 1,836,722 | -45.1% | 0.00% | – |
| Q4 2020 | $5,318,000 | +554.9% | 3,343,806 | +294.4% | 0.00% | – |
| Q3 2020 | $812,000 | +93.3% | 847,809 | +28.6% | 0.00% | – |
| Q2 2020 | $420,000 | +73.6% | 659,094 | +12.9% | 0.00% | – |
| Q1 2020 | $242,000 | -65.7% | 583,599 | -51.8% | 0.00% | – |
| Q4 2019 | $706,000 | +216.6% | 1,211,367 | +172.1% | 0.00% | – |
| Q3 2019 | $223,000 | -2.2% | 445,177 | -24.5% | 0.00% | – |
| Q2 2019 | $228,000 | +204.0% | 589,500 | +342.2% | 0.00% | – |
| Q1 2019 | $75,000 | -5.1% | 133,300 | -33.4% | 0.00% | – |
| Q4 2018 | $79,000 | -39.7% | 200,200 | -22.7% | 0.00% | – |
| Q3 2018 | $131,000 | -38.8% | 259,100 | +166.6% | 0.00% | – |
| Q2 2018 | $214,000 | -89.8% | 97,200 | -84.2% | 0.00% | – |
| Q1 2018 | $2,089,000 | +8.9% | 614,283 | +30.3% | 0.00% | – |
| Q4 2017 | $1,918,000 | +2359.0% | 471,507 | +212.4% | 0.00% | – |
| Q2 2017 | $78,000 | -87.9% | 150,925 | -81.2% | 0.00% | – |
| Q1 2017 | $642,000 | -70.1% | 803,300 | -66.3% | 0.00% | -100.0% |
| Q4 2016 | $2,147,000 | +829.4% | 2,384,500 | +1231.6% | 0.00% | – |
| Q2 2016 | $231,000 | -75.1% | 179,076 | -56.5% | 0.00% | – |
| Q1 2016 | $926,000 | -62.8% | 411,455 | -42.2% | 0.00% | -100.0% |
| Q4 2015 | $2,492,000 | +85.1% | 712,102 | +52.9% | 0.00% | – |
| Q3 2015 | $1,346,000 | -18.9% | 465,681 | -32.6% | 0.00% | -100.0% |
| Q2 2015 | $1,659,000 | -63.9% | 691,363 | +13.3% | 0.00% | -66.7% |
| Q1 2015 | $4,595,000 | +402.7% | 610,235 | +129.0% | 0.00% | – |
| Q4 2014 | $914,000 | -43.5% | 266,521 | -41.8% | 0.00% | – |
| Q3 2014 | $1,617,000 | -76.2% | 457,908 | -43.6% | 0.00% | -100.0% |
| Q2 2014 | $6,781,000 | +113.0% | 812,093 | +62.0% | 0.00% | +50.0% |
| Q1 2014 | $3,184,000 | +273.3% | 501,276 | +319.1% | 0.00% | – |
| Q4 2013 | $853,000 | -81.1% | 119,600 | -80.1% | 0.00% | -100.0% |
| Q3 2013 | $4,506,000 | +2296.8% | 600,692 | +1742.6% | 0.00% | – |
| Q2 2013 | $188,000 | – | 32,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|